COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Post by testfreakon Sep 10, 2015 11:46pm

161 Views

Post# 24094940

Horn

Listen to the webcast on website. The company said the warrants at 0.$21 common was like 10 commons for each warrant. So it's like 22/1. They not even close to done. I WAS DEAD WRONG At. 0.095 sold 0.09. This could see .03. Dilution is just way to large here. Management should be ashsmed

Bullboard Posts

Unique Battery Metals opportunity in Quebec